Table 1 Clinical characteristics of LUAD patients in TCGA.
From: GREB1L overexpression correlates with prognosis and immune cell infiltration in lung adenocarcinoma
Clinical characteristics | Total (497) | Percentage (%) |
|---|---|---|
Gender | ||
Male | 228 | 45.9 |
Female | 269 | 54.1 |
Age | ||
 ≤ 65 years old | 236 | 47.5 |
 > 65 years old | 251 | 50.5 |
Number pack years smoked | ||
 < 40 | 167 | 33.6 |
 ≥ 40 | 174 | 35.0 |
T stage | ||
T1 | 166 | 33.4 |
T2 | 267 | 53.7 |
T3 | 43 | 8.7 |
T4 | 18 | 3.6 |
N stage | ||
N0 | 321 | 64.6 |
N1 | 94 | 18.9 |
N2 | 69 | 13.9 |
N3 | 2 | 0.4 |
M stage | ||
M0 | 331 | 66.6 |
M1 | 24 | 4.8 |
TNM stage | ||
Stage 1 | 267 | 53.7 |
Stage 2 | 118 | 23.7 |
Stage 3 | 80 | 16.1 |
Stage 4 | 25 | 5.0 |
Vital status | ||
Dead | 180 | 36.2 |
Alive | 317 | 63.8 |
GREB1L expression | ||
Low | 248 | 49.9 |
High | 249 | 50.1 |
